Showing results (71-80 of 236) with videos related to

Sort By:
Pageof 24
Nucleic Acids Research|March 23, 2005
A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sitesQuan Du, Håkan Thonberg, Jue Wang, et al.
Oncotarget|February 1, 2019
Precision medicine in the treatment stratification of AML patients: challenges and progressInes Lohse, Kurt Statz-Geary, Shaun P Brothers, et al.
Genome Medicine|September 10, 2016
Epigenomic and metabolic responses of hypothalamic POMC neurons to gestational nicotine exposure in adult offspringJose P Silva, Guerline Lambert, Derek van Booven, et al.
Neurobiology of Disease|October 20, 2020
Molecular mechanisms of psychiatric diseasesIlya O Blokhin, Olga Khorkova, Radu V Saveanu, et al.
Critical Reviews in Clinical Laboratory Sciences|February 17, 2021
Molecular diagnostic assays for COVID-19: an overviewParham Habibzadeh, Mohammad Mofatteh, Mohammad Silawi, et al.
Biochemical and Biophysical Research Communications|November 4, 2004
Validating siRNA using a reporter made from synthetic DNA oligonucleotidesQuan Du, Håkan Thonberg, Hong-Yan Zhang, et al.
Journal of Rnai and Gene Silencing : an International Journal of RNA and Gene Targeting Research|September 23, 2009
Vector-based siRNA delivery strategies for high-throughput screening of novel target genesMeihong Chen, Quan Du, Hong-Yan Zhang, et al.
Regulatory Peptides|July 2, 2003
Behavioural analysis of melanin-concentrating hormone in rats: evidence for orexigenic and anxiolytic propertiesJohanna Kela, Peter Salmi, Roberto Rimondini-Giorgini, et al.
Microbiology (Reading, England)|October 6, 2000
Antisense PNA effects in Escherichia coli are limited by the outer-membrane LPS layerLiam Good, Rickard Sandberg, Ola Larsson, et al.
Human Molecular Genetics|February 8, 2017
The FMR1 promoter is selectively hydroxymethylated in primary neurons of fragile X syndrome patientsRustam Esanov, Nadja S Andrade, Sarah Bennison, et al.
Pageof 24